Liquid Handler Workstation suits drug discovery laboratories.
Share:
Press Release Summary:
Intended for drug discovery, proteomic, and genomic research, NanoRAPTR provides non-contact liquid handling of cells, protein solutions, dimethyl sulfoxide solutions, and viscous solutions into low volume microplates. Workstation rapidly aspirates and dispenses up to 8 reagents for volumes starting at 100 nL using on-the-fly motion.
Original Press Release:
Aurora Discovery Introduces the NanoRAPTR for Drug Discovery Laboratories
SAN DIEGO, Jan. 31 - Aurora Discovery today announced it has introduced a new liquid handler for rapid, low-volume sample delivery in drug discovery, proteomic, and genomic research. The NanoRAPTR workstation provides researchers with non-contact liquid handling of cells, protein solutions, dimethyl sulfoxide (DMSO) solutions, and viscous solutions into low volume microplates. This workstation rapidly aspirates and dispenses up to eight reagents for volumes starting at 100 nL using on-the-fly motion with extremely high precision and accuracy.
"With the introduction of the NanoRAPTR, Aurora Discovery now offers a comprehensive product line of non-contact liquid handling and dispensing workstations for miniaturizing assay formats," said Peter Coassin, Aurora Discovery's President and CTO. "When used in conjunction with the BioRAPTR FRD, PicoRAPTR, and Scout MPD workstations -- laboratory researchers can produce substantial results in low volume assays." This product will be showcased at the Laboratory Automation Conference being held in San Jose, California from January 31 to February 3, 2005.
Aurora Discovery, Inc. is a leading provider of miniaturization solutions for discovery sciences. The company designs, manufactures, markets, and supports instrumentation and consumables for pharmaceutical research, particularly drug discovery and chemical genomics. Aurora Discovery's products accelerate drug discovery and help its pharmaceutical customers to select novel chemical entities quicker and ultimately, develop new medicines and therapies more rapidly and cost-effectively. Located in San Diego, California, the company provides high value solutions to the pharmaceutical research challenge through high-density microplate formats, precision non-contact dispensers for chemical compounds and biological reagents, multi-wavelength fluorescence detectors, and systems integration. For more information, visit Aurora Discovery on its website at www.auroradiscovery.com.
CONTACT: Chris Biagioli, Marketing Manager of Aurora Discovery, Inc., +1-858-334-4508, marcom@auroradiscovery.com
